Maxim Group upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Hold to Buy with a price target of $6.00 citing 2014 catalysts.
This article: 117 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE